Japanese law firm Nishimura & Asahi has represented private equity group MBK Partners on its acquisition of drugmaker Alinamin Pharmaceuticals for 350 billion yen ($2.17 billion) from PE giant Blackstone, which was advised by its longstanding firm Simpson Thacher & Bartlett.